Guillain-Barre Syndrome in a patient with uterine adenocarcinoma undergoing treatment with immune-checkpoint inhibitor therapy: A case report and review of the literature

BACKGROUND: Use of immune checkpoint inhibitors in treatment of gynecologic malignancies is increasing. Rare, but potentially fatal, immune-related neurologic adverse events may occur as a result of treatment. CASE: A 72 year old female with recurrent metastatic uterine adenocarcinoma received pembr...

Descripción completa

Detalles Bibliográficos
Autores principales: Brzezinska, Bogna N., Higgins, Robert V., Rungruang, Bunja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967007/
https://www.ncbi.nlm.nih.gov/pubmed/33748382
http://dx.doi.org/10.1016/j.gore.2021.100739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967007/
https://www.ncbi.nlm.nih.gov/pubmed/33748382
http://dx.doi.org/10.1016/j.gore.2021.100739

Ejemplares similares